This fertility benefit business is set to boom. Buy the stock now, Wells Fargo says
Progyny is set to benefit from several structural tailwinds, including catalysts that should help it court more clients, according to Wells Fargo.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.